- 0208 903 4819
- Weekday Hours: 10AM - 5PM
The disorder known as erectile dysfunction (ED) is characterised by an inability to achieve or maintain an
erection strong enough for fulfilling sexual activity. ED may be a transient issue or a chronic one. When you
have ED, you can occasionally achieve an erection, but not every time you may feel intimate. This means
you are not always able to have satisfying or happy sex. According to recent epidemiologic studies, 10% of
men between the ages of 40 and 70 are thought to have severe or total erectile dysfunction. Men who are
overweight or obese can suffer from ED as it could be linked to a psychological issue such as low mood,
not feeling confident but also linked to health and diet.
The disorder known as erectile dysfunction (ED) is characterised by an inability to achieve or maintain an
erection strong enough for fulfilling sexual activity. ED may be a transient issue or a chronic one. When you
have ED, you can occasionally achieve an erection, but not every time you may feel intimate. This means you are not always able to have satisfying or happy sex. According to recent epidemiologic studies, 10% of men between the ages of 40 and 70 are thought to have severe or total erectile dysfunction. Men who are overweight or obese can suffer from ED as it could be linked to a psychological issue such as low mood,
not feeling confident but also linked to health and diet.
Wegovy may be useful in managing overweight men with erectile dysfunction.
Weight loss improves the ability to maintain an erection as well as can improve
self-esteem so Wegovy can be used to help reach a healthy weight range. After
the doctor reviews the patient in a consultation, it will determine if the patient is
suitable to use the medication. The patient would start on the starter dose of
0.25mg if approved for Wegovy.
Wegovy may be useful in managing overweight men with erectile dysfunction. Weight loss improves the ability to maintain an erection as well as can improve self-esteem so Wegovy can be used to help reach a healthy weight range. After the doctor reviews the patient in a consultation, it will determine if the patient is suitable to use the medication. The patient would start on the starter dose of 0.25mg if approved for Wegovy.
Semaglutide, a medication for type 2 diabetes, is marketed under the name Wegovy. Semaglutide are members of
the glucagon-like peptide-1 (GLP-1) receptor agonist drug class. These drugs imitate the functions of the GLP-1
hormone, which aids in controlling body weight, food consumption, and hunger. By slowing down the time it takes
to digest the food consumed, it makes the person feel fuller for longer which in turn reduces food intake. This
accompanied with a healthy lifestyle will lead to successful weight loss outcomes.
Semaglutide, a medication for type 2 diabetes, is marketed under the name Wegovy. Semaglutide are members of
the glucagon-like peptide-1 (GLP-1) receptor agonist drug class. These drugs imitate the functions of the GLP-1 hormone, which aids in controlling body weight, food consumption, and hunger. By slowing down the time it takes to digest the food consumed, it makes the person feel fuller for longer which in turn reduces food intake. This
accompanied with a healthy lifestyle will lead to successful weight loss outcomes.
Studies concluded that using GLP-1 receptor agonists may help lower your chance of
developing ED. Researchers have found that men with type 2 diabetes and obesity have
higher testosterone levels. Studies have shown successful weight loss for those taking
semaglutide. With obesity being linked to ED, successful weight loss should improve ED.
Studies concluded that using GLP-1 receptor agonists may help lower your chance of developing ED. Researchers have found that men with type 2 diabetes and obesity have higher testosterone levels. Studies have shown successful weight loss for those taking semaglutide. With obesity being linked to ED, successful weight loss should improve ED.
Before recommending Wegovy for weight control, medical
professionals will evaluate a number of aspects, including general
health and BMI. If the patient meets the eligibility requirements and
the medicine is deemed appropriate for managing their weight, they
can be prescribed Wegovy. There maybe a few factors preventing
the prescribing of Wegovy such as Thyroid cancer or any medical
conditions which could be a health risk. The patient must be
reviewed by a healthcare professional to be reviewed for the
suitability of the medication.
Before recommending Wegovy for weight control, medical professionals will evaluate a number of aspects, including general health and BMI. If the patient meets the eligibility requirements and the medicine is deemed appropriate for managing their weight, they can be prescribed Wegovy. There maybe a few factors preventing the prescribing of Wegovy such as Thyroid cancer or any medical conditions which could be a health risk. The patient must be reviewed by a healthcare professional to be reviewed for the suitability of the medication.
Read our articles on Wegovy & Mounjaro if you would like to learn more about the benefits, the research and case studies.
Videos created by our chief doctor on managing and understanding Wegovy to help you achieve the best outcomes possible.
Book an Appointment Today
All consultations and prescriptions are carried out by GMC registered medical practitioners.
All dispensing and shipping of medicines are completed by a UK licensed, GPhC registered Pharmacy no: 9011284.
CloudRx is our partner pharmacy and prescribing service.
*Disclaimer: Results may vary from person to person depending on individual engagement and commitment to the programme.
The content of this website is provided for general informational purposes only and is not intended as, nor should it be considered a substitute for, professional medical advice. Do not use the information on this website for diagnosing or treating any medical or health related condition. If you have or suspect you have a medical problem, promptly contact your healthcare provider.
© 2023 The London Obesity Clinic
